View Future GrowthThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsBiofactory 과거 순이익 실적과거 기준 점검 0/6Biofactory 의 수입은 연평균 -1.8%의 비율로 감소해 온 반면, Forestry 산업은 연평균 8.2%의 비율로 감소했습니다. 매출은 연평균 6%의 비율로 증가해 왔습니다.핵심 정보-1.84%순이익 성장률-1.84%주당순이익(EPS) 성장률Forestry 산업 성장률28.94%매출 성장률5.98%자기자본이익률-6.43%순이익률-2.62%다음 순이익 업데이트14 Aug 2024최근 과거 실적 업데이트Reported Earnings • Feb 18Full year 2023 earnings released: zł0.10 loss per share (vs zł0.56 profit in FY 2022)Full year 2023 results: zł0.10 loss per share (down from zł0.56 profit in FY 2022). Revenue: zł14.6m (down 13% from FY 2022). Net loss: zł196.0k (down 119% from profit in FY 2022). Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings.공시 • Jan 07Biofactory S.A. to Report Q1, 2024 Results on May 14, 2024Biofactory S.A. announced that they will report Q1, 2024 results on May 14, 2024공시 • Jan 06+ 3 more updatesBiofactory S.A. to Report Q3, 2024 Results on Nov 14, 2024Biofactory S.A. announced that they will report Q3, 2024 results on Nov 14, 2024Reported Earnings • Aug 02Second quarter 2023 earnings releasedSecond quarter 2023 results: Revenue: zł3.63m (down 24% from 2Q 2022). Net loss: zł5.8k (down 102% from profit in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.Reported Earnings • Feb 02Full year 2022 earnings released: EPS: zł0.56 (vs zł0.56 in FY 2021)Full year 2022 results: EPS: zł0.56 (down from zł0.56 in FY 2021). Revenue: zł16.7m (up 5.6% from FY 2021). Net income: zł1.06m (flat on FY 2021). Profit margin: 6.3% (down from 6.7% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth.공시 • Nov 03+ 4 more updatesBiofactory S.A. to Report Q2, 2023 Results on Jul 31, 2023Biofactory S.A. announced that they will report Q2, 2023 results on Jul 31, 2023모든 업데이트 보기Recent updates공시 • Apr 19Biofactory S.A., Annual General Meeting, May 13, 2024Biofactory S.A., Annual General Meeting, May 13, 2024, at 09:00 Central European Standard Time.Reported Earnings • Feb 18Full year 2023 earnings released: zł0.10 loss per share (vs zł0.56 profit in FY 2022)Full year 2023 results: zł0.10 loss per share (down from zł0.56 profit in FY 2022). Revenue: zł14.6m (down 13% from FY 2022). Net loss: zł196.0k (down 119% from profit in FY 2022). Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings.Buy Or Sell Opportunity • Feb 08Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 16% to zł3.94. The fair value is estimated to be zł3.23, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 9.9% over the last 3 years. Meanwhile, the company became loss making.Buy Or Sell Opportunity • Jan 19Now 31% overvaluedOver the last 90 days, the stock has fallen 6.2% to zł3.94. The fair value is estimated to be zł3.01, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 9.9% over the last 3 years. Meanwhile, the company became loss making.공시 • Jan 07Biofactory S.A. to Report Q1, 2024 Results on May 14, 2024Biofactory S.A. announced that they will report Q1, 2024 results on May 14, 2024공시 • Jan 06+ 3 more updatesBiofactory S.A. to Report Q3, 2024 Results on Nov 14, 2024Biofactory S.A. announced that they will report Q3, 2024 results on Nov 14, 2024분석 기사 • Nov 04A Look At The Intrinsic Value Of Biofactory S.A. (WSE:BFC)Key Insights The projected fair value for Biofactory is zł3.09 based on Dividend Discount Model Biofactory's zł3.50...Valuation Update With 7 Day Price Move • Oct 24Investor sentiment improves as stock rises 18%After last week's 18% share price gain to zł4.14, the stock trades at a trailing P/E ratio of 18.8x. Average trailing P/E is 15x in the Forestry industry in Poland. Total returns to shareholders of 71% over the past three years.Valuation Update With 7 Day Price Move • Oct 05Investor sentiment improves as stock rises 18%After last week's 18% share price gain to zł3.78, the stock trades at a trailing P/E ratio of 17.2x. Average trailing P/E is 13x in the Forestry industry in Poland. Total returns to shareholders of 56% over the past three years.Valuation Update With 7 Day Price Move • Sep 14Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to zł3.80, the stock trades at a trailing P/E ratio of 17.3x. Average trailing P/E is 15x in the Forestry industry in Poland. Total returns to shareholders of 17% over the past three years.Reported Earnings • Aug 02Second quarter 2023 earnings releasedSecond quarter 2023 results: Revenue: zł3.63m (down 24% from 2Q 2022). Net loss: zł5.8k (down 102% from profit in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Jun 20Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to zł4.00, the stock trades at a trailing P/E ratio of 10.7x. Average trailing P/E is 11x in the Forestry industry in Poland. Total returns to shareholders of 76% over the past three years.Upcoming Dividend • Jun 06Upcoming dividend of zł0.30 per share at 6.7% yieldEligible shareholders must have bought the stock before 13 June 2023. Payment date: 27 June 2023. Payout ratio is on the higher end at 80%, and the cash payout ratio is above 100%. Trailing yield: 6.7%. Lower than top quartile of Polish dividend payers (7.4%). Higher than average of industry peers (5.6%).공시 • May 09Biofactory S.A., Annual General Meeting, Jun 02, 2023Biofactory S.A., Annual General Meeting, Jun 02, 2023, at 10:00 Central European Standard Time.Reported Earnings • Feb 02Full year 2022 earnings released: EPS: zł0.56 (vs zł0.56 in FY 2021)Full year 2022 results: EPS: zł0.56 (down from zł0.56 in FY 2021). Revenue: zł16.7m (up 5.6% from FY 2021). Net income: zł1.06m (flat on FY 2021). Profit margin: 6.3% (down from 6.7% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Jan 16Investor sentiment improved over the past weekAfter last week's 19% share price gain to zł4.52, the stock trades at a trailing P/E ratio of 9.4x. Average trailing P/E is 11x in the Forestry industry in Poland. Total returns to shareholders of 87% over the past three years.Valuation Update With 7 Day Price Move • Dec 16Investor sentiment improved over the past weekAfter last week's 20% share price gain to zł3.98, the stock trades at a trailing P/E ratio of 8.3x. Average trailing P/E is 9x in the Forestry industry in Poland. Total returns to shareholders of 65% over the past three years.Valuation Update With 7 Day Price Move • Nov 30Investor sentiment improved over the past weekAfter last week's 25% share price gain to zł3.64, the stock trades at a trailing P/E ratio of 7.6x. Average trailing P/E is 9x in the Forestry industry in Poland. Total returns to shareholders of 70% over the past three years.공시 • Nov 03+ 4 more updatesBiofactory S.A. to Report Q2, 2023 Results on Jul 31, 2023Biofactory S.A. announced that they will report Q2, 2023 results on Jul 31, 2023Reported Earnings • Aug 02Second quarter 2022 earnings released: EPS: zł0.15 (vs zł0.38 in 2Q 2021)Second quarter 2022 results: EPS: zł0.15 (down from zł0.38 in 2Q 2021). Revenue: zł4.79m (up 12% from 2Q 2021). Net income: zł288.2k (down 60% from 2Q 2021). Profit margin: 6.0% (down from 17% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Jul 28Investor sentiment improved over the past weekAfter last week's 22% share price gain to zł4.36, the stock trades at a trailing P/E ratio of 6.2x. Average trailing P/E is 14x in the Forestry industry in Poland. Total returns to shareholders of 114% over the past three years.분석 기사 • Jul 11Should You Be Adding Biofactory (WSE:BFC) To Your Watchlist Today?For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...Valuation Update With 7 Day Price Move • Jun 20Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to zł3.60, the stock trades at a trailing P/E ratio of 5.1x. Average trailing P/E is 7x in the Forestry industry in Poland. Total returns to shareholders of 72% over the past three years.Upcoming Dividend • Jun 03Upcoming dividend of zł0.27 per shareEligible shareholders must have bought the stock before 10 June 2022. Payment date: 22 June 2022. Payout ratio is a comfortable 38% and this is well supported by cash flows. Trailing yield: 6.1%. Lower than top quartile of Polish dividend payers (7.9%). Higher than average of industry peers (3.2%).공시 • May 03Biofactory S.A., Annual General Meeting, Jun 02, 2022Biofactory S.A., Annual General Meeting, Jun 02, 2022, at 10:00 Central European Standard Time.Reported Earnings • Feb 02Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: zł0.55 (up from zł0.045 in FY 2020). Revenue: zł15.9m (up 38% from FY 2020). Net income: zł1.04m (up zł952.8k from FY 2020). Profit margin: 6.5% (up from 0.7% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Dec 22Investor sentiment deteriorated over the past weekAfter last week's 23% share price decline to zł3.60, the stock trades at a trailing P/E ratio of 4.9x. Average trailing P/E is 12x in the Forestry industry in Poland. Total returns to shareholders of 48% over the past three years.Valuation Update With 7 Day Price Move • Nov 04Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to zł4.36, the stock trades at a trailing P/E ratio of 5.9x. Average trailing P/E is 12x in the Forestry industry in Poland. Total returns to shareholders of 73% over the past three years.Valuation Update With 7 Day Price Move • Oct 21Investor sentiment improved over the past weekAfter last week's 18% share price gain to zł4.78, the stock trades at a trailing P/E ratio of 8.2x. Average trailing P/E is 12x in the Forestry industry in Poland. Total returns to shareholders of 89% over the past three years.Reported Earnings • Aug 04Second quarter 2021 earnings releasedThe company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: zł4.28m (up 57% from 2Q 2020). Net income: zł715.4k (up zł890.7k from 2Q 2020). Profit margin: 17% (up from net loss in 2Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 59% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Aug 03Investor sentiment improved over the past weekAfter last week's 37% share price gain to zł4.42, the stock trades at a trailing P/E ratio of 35.6x. Average trailing P/E is 20x in the Forestry industry in Poland. Total returns to shareholders of 44% over the past three years.Upcoming Dividend • Jun 25Upcoming dividend of zł0.15 per shareEligible shareholders must have bought the stock before 02 July 2021. Payment date: 26 August 2021. Trailing yield: 4.2%. Lower than top quartile of Polish dividend payers (5.8%). Higher than average of industry peers (2.8%).Valuation Update With 7 Day Price Move • Jun 01Investor sentiment improved over the past weekAfter last week's 15% share price gain to zł3.64, the stock trades at a trailing P/E ratio of 29.3x. Average trailing P/E is 20x in the Forestry industry in Poland. Total returns to shareholders of 40% over the past three years.Valuation Update With 7 Day Price Move • May 04Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to zł3.30, the stock trades at a trailing P/E ratio of 73.8x. Average trailing P/E is 22x in the Forestry industry in Poland. Total returns to shareholders of 27% over the past three years.Valuation Update With 7 Day Price Move • Feb 04Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to zł3.30, the stock is trading at a trailing P/E ratio of 73.8x, down from the previous P/E ratio of 89x. This compares to an average P/E of 25x in the Forestry industry in Poland. Total returns to shareholders over the past three years are 18%.분석 기사 • Feb 03Calculating The Fair Value Of Biofactory S.A. (WSE:BFC)How far off is Biofactory S.A. ( WSE:BFC ) from its intrinsic value? Using the most recent financial data, we'll take a...Reported Earnings • Feb 03Full year 2020 earnings released: EPS zł0.045 (vs zł0.24 in FY 2019)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: zł11.5m (down 11% from FY 2019). Net income: zł85.0k (down 82% from FY 2019). Profit margin: 0.7% (down from 3.6% in FY 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings.공시 • Dec 12+ 4 more updatesBiofactory S.A. to Report Q3, 2021 Results on Oct 29, 2021Biofactory S.A. announced that they will report Q3, 2021 results on Oct 29, 2021매출 및 비용 세부 내역Biofactory가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이WSE:BFC 매출, 비용 및 순이익 (PLN Millions)날짜매출순이익일반관리비연구개발비31 Mar 241505031 Dec 231505030 Sep 231504030 Jun 231604031 Mar 231715031 Dec 221715030 Sep 221715030 Jun 221715031 Mar 221614031 Dec 211614030 Sep 211514030 Jun 211414031 Mar 211203031 Dec 201203030 Sep 201203030 Jun 201203031 Mar 201303031 Dec 191303030 Sep 191303030 Jun 191313031 Mar 191213031 Dec 181213030 Sep 181213030 Jun 181203031 Mar 181303031 Dec 171203030 Sep 171203030 Jun 171103031 Mar 171103031 Dec 161003030 Sep 161003030 Jun 161003031 Mar 161003031 Dec 15903030 Sep 15902030 Jun 15902031 Mar 151002031 Dec 141002030 Sep 14902030 Jun 14902031 Mar 14902031 Dec 13802030 Sep 138020양질의 수익: BFC 은(는) 현재 수익성이 없습니다.이익 마진 증가: BFC는 현재 수익성이 없습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: BFC은 수익성이 없으며 지난 5년 동안 손실이 연평균 1.8% 증가했습니다.성장 가속화: 현재 수익성이 없어 지난 1년간 BFC의 수익 성장률을 5년 평균과 비교할 수 없습니다.수익 대 산업: BFC은 수익성이 없어 지난 해 수익 성장률을 Forestry 업계(-24%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: BFC는 현재 수익성이 없으므로 자본 수익률이 음수(-6.43%)입니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YMaterials 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2024/07/14 08:17종가2024/04/17 00:00수익2024/03/31연간 수익2023/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Biofactory S.A.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
Reported Earnings • Feb 18Full year 2023 earnings released: zł0.10 loss per share (vs zł0.56 profit in FY 2022)Full year 2023 results: zł0.10 loss per share (down from zł0.56 profit in FY 2022). Revenue: zł14.6m (down 13% from FY 2022). Net loss: zł196.0k (down 119% from profit in FY 2022). Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings.
공시 • Jan 07Biofactory S.A. to Report Q1, 2024 Results on May 14, 2024Biofactory S.A. announced that they will report Q1, 2024 results on May 14, 2024
공시 • Jan 06+ 3 more updatesBiofactory S.A. to Report Q3, 2024 Results on Nov 14, 2024Biofactory S.A. announced that they will report Q3, 2024 results on Nov 14, 2024
Reported Earnings • Aug 02Second quarter 2023 earnings releasedSecond quarter 2023 results: Revenue: zł3.63m (down 24% from 2Q 2022). Net loss: zł5.8k (down 102% from profit in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Feb 02Full year 2022 earnings released: EPS: zł0.56 (vs zł0.56 in FY 2021)Full year 2022 results: EPS: zł0.56 (down from zł0.56 in FY 2021). Revenue: zł16.7m (up 5.6% from FY 2021). Net income: zł1.06m (flat on FY 2021). Profit margin: 6.3% (down from 6.7% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth.
공시 • Nov 03+ 4 more updatesBiofactory S.A. to Report Q2, 2023 Results on Jul 31, 2023Biofactory S.A. announced that they will report Q2, 2023 results on Jul 31, 2023
공시 • Apr 19Biofactory S.A., Annual General Meeting, May 13, 2024Biofactory S.A., Annual General Meeting, May 13, 2024, at 09:00 Central European Standard Time.
Reported Earnings • Feb 18Full year 2023 earnings released: zł0.10 loss per share (vs zł0.56 profit in FY 2022)Full year 2023 results: zł0.10 loss per share (down from zł0.56 profit in FY 2022). Revenue: zł14.6m (down 13% from FY 2022). Net loss: zł196.0k (down 119% from profit in FY 2022). Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings.
Buy Or Sell Opportunity • Feb 08Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 16% to zł3.94. The fair value is estimated to be zł3.23, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 9.9% over the last 3 years. Meanwhile, the company became loss making.
Buy Or Sell Opportunity • Jan 19Now 31% overvaluedOver the last 90 days, the stock has fallen 6.2% to zł3.94. The fair value is estimated to be zł3.01, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 9.9% over the last 3 years. Meanwhile, the company became loss making.
공시 • Jan 07Biofactory S.A. to Report Q1, 2024 Results on May 14, 2024Biofactory S.A. announced that they will report Q1, 2024 results on May 14, 2024
공시 • Jan 06+ 3 more updatesBiofactory S.A. to Report Q3, 2024 Results on Nov 14, 2024Biofactory S.A. announced that they will report Q3, 2024 results on Nov 14, 2024
분석 기사 • Nov 04A Look At The Intrinsic Value Of Biofactory S.A. (WSE:BFC)Key Insights The projected fair value for Biofactory is zł3.09 based on Dividend Discount Model Biofactory's zł3.50...
Valuation Update With 7 Day Price Move • Oct 24Investor sentiment improves as stock rises 18%After last week's 18% share price gain to zł4.14, the stock trades at a trailing P/E ratio of 18.8x. Average trailing P/E is 15x in the Forestry industry in Poland. Total returns to shareholders of 71% over the past three years.
Valuation Update With 7 Day Price Move • Oct 05Investor sentiment improves as stock rises 18%After last week's 18% share price gain to zł3.78, the stock trades at a trailing P/E ratio of 17.2x. Average trailing P/E is 13x in the Forestry industry in Poland. Total returns to shareholders of 56% over the past three years.
Valuation Update With 7 Day Price Move • Sep 14Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to zł3.80, the stock trades at a trailing P/E ratio of 17.3x. Average trailing P/E is 15x in the Forestry industry in Poland. Total returns to shareholders of 17% over the past three years.
Reported Earnings • Aug 02Second quarter 2023 earnings releasedSecond quarter 2023 results: Revenue: zł3.63m (down 24% from 2Q 2022). Net loss: zł5.8k (down 102% from profit in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Jun 20Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to zł4.00, the stock trades at a trailing P/E ratio of 10.7x. Average trailing P/E is 11x in the Forestry industry in Poland. Total returns to shareholders of 76% over the past three years.
Upcoming Dividend • Jun 06Upcoming dividend of zł0.30 per share at 6.7% yieldEligible shareholders must have bought the stock before 13 June 2023. Payment date: 27 June 2023. Payout ratio is on the higher end at 80%, and the cash payout ratio is above 100%. Trailing yield: 6.7%. Lower than top quartile of Polish dividend payers (7.4%). Higher than average of industry peers (5.6%).
공시 • May 09Biofactory S.A., Annual General Meeting, Jun 02, 2023Biofactory S.A., Annual General Meeting, Jun 02, 2023, at 10:00 Central European Standard Time.
Reported Earnings • Feb 02Full year 2022 earnings released: EPS: zł0.56 (vs zł0.56 in FY 2021)Full year 2022 results: EPS: zł0.56 (down from zł0.56 in FY 2021). Revenue: zł16.7m (up 5.6% from FY 2021). Net income: zł1.06m (flat on FY 2021). Profit margin: 6.3% (down from 6.7% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Jan 16Investor sentiment improved over the past weekAfter last week's 19% share price gain to zł4.52, the stock trades at a trailing P/E ratio of 9.4x. Average trailing P/E is 11x in the Forestry industry in Poland. Total returns to shareholders of 87% over the past three years.
Valuation Update With 7 Day Price Move • Dec 16Investor sentiment improved over the past weekAfter last week's 20% share price gain to zł3.98, the stock trades at a trailing P/E ratio of 8.3x. Average trailing P/E is 9x in the Forestry industry in Poland. Total returns to shareholders of 65% over the past three years.
Valuation Update With 7 Day Price Move • Nov 30Investor sentiment improved over the past weekAfter last week's 25% share price gain to zł3.64, the stock trades at a trailing P/E ratio of 7.6x. Average trailing P/E is 9x in the Forestry industry in Poland. Total returns to shareholders of 70% over the past three years.
공시 • Nov 03+ 4 more updatesBiofactory S.A. to Report Q2, 2023 Results on Jul 31, 2023Biofactory S.A. announced that they will report Q2, 2023 results on Jul 31, 2023
Reported Earnings • Aug 02Second quarter 2022 earnings released: EPS: zł0.15 (vs zł0.38 in 2Q 2021)Second quarter 2022 results: EPS: zł0.15 (down from zł0.38 in 2Q 2021). Revenue: zł4.79m (up 12% from 2Q 2021). Net income: zł288.2k (down 60% from 2Q 2021). Profit margin: 6.0% (down from 17% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Jul 28Investor sentiment improved over the past weekAfter last week's 22% share price gain to zł4.36, the stock trades at a trailing P/E ratio of 6.2x. Average trailing P/E is 14x in the Forestry industry in Poland. Total returns to shareholders of 114% over the past three years.
분석 기사 • Jul 11Should You Be Adding Biofactory (WSE:BFC) To Your Watchlist Today?For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Valuation Update With 7 Day Price Move • Jun 20Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to zł3.60, the stock trades at a trailing P/E ratio of 5.1x. Average trailing P/E is 7x in the Forestry industry in Poland. Total returns to shareholders of 72% over the past three years.
Upcoming Dividend • Jun 03Upcoming dividend of zł0.27 per shareEligible shareholders must have bought the stock before 10 June 2022. Payment date: 22 June 2022. Payout ratio is a comfortable 38% and this is well supported by cash flows. Trailing yield: 6.1%. Lower than top quartile of Polish dividend payers (7.9%). Higher than average of industry peers (3.2%).
공시 • May 03Biofactory S.A., Annual General Meeting, Jun 02, 2022Biofactory S.A., Annual General Meeting, Jun 02, 2022, at 10:00 Central European Standard Time.
Reported Earnings • Feb 02Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: zł0.55 (up from zł0.045 in FY 2020). Revenue: zł15.9m (up 38% from FY 2020). Net income: zł1.04m (up zł952.8k from FY 2020). Profit margin: 6.5% (up from 0.7% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Dec 22Investor sentiment deteriorated over the past weekAfter last week's 23% share price decline to zł3.60, the stock trades at a trailing P/E ratio of 4.9x. Average trailing P/E is 12x in the Forestry industry in Poland. Total returns to shareholders of 48% over the past three years.
Valuation Update With 7 Day Price Move • Nov 04Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to zł4.36, the stock trades at a trailing P/E ratio of 5.9x. Average trailing P/E is 12x in the Forestry industry in Poland. Total returns to shareholders of 73% over the past three years.
Valuation Update With 7 Day Price Move • Oct 21Investor sentiment improved over the past weekAfter last week's 18% share price gain to zł4.78, the stock trades at a trailing P/E ratio of 8.2x. Average trailing P/E is 12x in the Forestry industry in Poland. Total returns to shareholders of 89% over the past three years.
Reported Earnings • Aug 04Second quarter 2021 earnings releasedThe company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: zł4.28m (up 57% from 2Q 2020). Net income: zł715.4k (up zł890.7k from 2Q 2020). Profit margin: 17% (up from net loss in 2Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 59% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Aug 03Investor sentiment improved over the past weekAfter last week's 37% share price gain to zł4.42, the stock trades at a trailing P/E ratio of 35.6x. Average trailing P/E is 20x in the Forestry industry in Poland. Total returns to shareholders of 44% over the past three years.
Upcoming Dividend • Jun 25Upcoming dividend of zł0.15 per shareEligible shareholders must have bought the stock before 02 July 2021. Payment date: 26 August 2021. Trailing yield: 4.2%. Lower than top quartile of Polish dividend payers (5.8%). Higher than average of industry peers (2.8%).
Valuation Update With 7 Day Price Move • Jun 01Investor sentiment improved over the past weekAfter last week's 15% share price gain to zł3.64, the stock trades at a trailing P/E ratio of 29.3x. Average trailing P/E is 20x in the Forestry industry in Poland. Total returns to shareholders of 40% over the past three years.
Valuation Update With 7 Day Price Move • May 04Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to zł3.30, the stock trades at a trailing P/E ratio of 73.8x. Average trailing P/E is 22x in the Forestry industry in Poland. Total returns to shareholders of 27% over the past three years.
Valuation Update With 7 Day Price Move • Feb 04Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to zł3.30, the stock is trading at a trailing P/E ratio of 73.8x, down from the previous P/E ratio of 89x. This compares to an average P/E of 25x in the Forestry industry in Poland. Total returns to shareholders over the past three years are 18%.
분석 기사 • Feb 03Calculating The Fair Value Of Biofactory S.A. (WSE:BFC)How far off is Biofactory S.A. ( WSE:BFC ) from its intrinsic value? Using the most recent financial data, we'll take a...
Reported Earnings • Feb 03Full year 2020 earnings released: EPS zł0.045 (vs zł0.24 in FY 2019)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: zł11.5m (down 11% from FY 2019). Net income: zł85.0k (down 82% from FY 2019). Profit margin: 0.7% (down from 3.6% in FY 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings.
공시 • Dec 12+ 4 more updatesBiofactory S.A. to Report Q3, 2021 Results on Oct 29, 2021Biofactory S.A. announced that they will report Q3, 2021 results on Oct 29, 2021